Byshevskii A Sh, Galian S L
Vopr Med Khim. 1980 Jan-Feb;26(1):85-8.
Content of a thermostable inhibitor of thrombinogenesis (antifactor Xa) was decreased in blood serum after administration of pellentan. Subsequent treatment with vicasol normalized at the accelerated rate the antifactor Xa content in blood serum. Administration of the inhibitors of protein synthesis (vincrystine, actinomycin D, toyomycin, tetracycline--inhibitors of RNA polymerase, elongation, posttranscriptional conversions of mRNA and of translation processes, respectively (did not alter distinctly the vicasol effect--decrease in antifactor Xa content of blood serum. Vitamin K appears to participate in formation of the active molecule of the inhibitor of thrombinogenesis at the postribosomal step as shown in study of several other blood plasma procoagulants.
给予培冷坦后,血清中凝血酶生成的热稳定抑制剂(抗Xa因子)含量降低。随后用维生素K3治疗可加速血清中抗Xa因子含量恢复正常。给予蛋白质合成抑制剂(长春新碱、放线菌素D、丰加霉素、四环素,分别为RNA聚合酶、延伸、mRNA转录后转化和翻译过程的抑制剂)并未明显改变维生素K3的作用——血清中抗Xa因子含量降低。正如对其他几种血浆促凝血剂的研究所表明的,维生素K似乎在核糖体后步骤参与凝血酶生成抑制剂活性分子的形成。